SCHEMBL16585360

SCHEMBL16585360

NC(=O)C(=O)c1ccc(-c2ccc(F)cc2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CES2 O00748 2/20 0.62
▸ CES1 P23141 2/20 0.62
▸ BCL2L1 Q07817 1/20 0.59
▸ BAD Q92934 1/20 0.59
▸ PTPN1 P18031 2/20 0.50
▸ CA1 P00915 2/20 0.46
▸ CA2 P00918 2/20 0.46
▸ PTGS1 P23219 1/20 0.45
▸ NQO2 P16083 1/20 0.44
▸ CHEK2 O96017 1/20 0.43
▸ MEN1 O00255 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ NPC1 O15118 2/20 0.42
▸ KCNN4 O15554 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ RXFP1 Q9HBX9 1/20 0.42
▸ MAP4K4 O95819 1/20 0.41
▸ LTA4H P09960 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3131476 0.93 CES2 (0.71) CES2CES1BCL2L1BADPTPN1
SCHEMBL1927476 0.82 BCL2L1 (0.64) CES2CES1BCL2L1BADPTPN1
SCHEMBL16595319 0.80 BCL2L1 (0.68) CES2CES1BCL2L1BADPTPN1
Hydrochloric Acid SCHEMBL30685286 0.80 BCL2L1 (0.61) CES2CES1BCL2L1BADPTPN1
SCHEMBL716295 0.78 CES2 (1.00) CES2CES1BCL2L1BADPTPN1
SCHEMBL9777084 0.77 BCL2L1 (0.70) CES2CES1BCL2L1BADPTPN1
SCHEMBL1864175 0.77 BCL2L1 (0.70) CES2CES1BCL2L1BADPTPN1
SCHEMBL9814506 0.77 BCL2L1 (0.70) CES2CES1BCL2L1BADPTPN1
SCHEMBL10313780 0.76 CES2 (0.65) CES2CES1BCL2L1BADPTPN1
SCHEMBL10704266 0.75 BCL2L1 (0.67) CES2CES1BCL2L1BADPTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3046920-A1 GLUCOSYLCERAMIDE SYNTHASE INHIBITORS FOR THE TREATMENT OF DISEASES BioMarin Pharmaceutical Inc. (US) 2016-07-27 — — EP claimed
WO-2015042397-A1 GLUCOSYLCERAMIDE SYNTHASE INHIBITORS FOR THE TREATMENT OF DISEASES BIOMARIN PHARMACEUTICAL INC. (US) 2015-03-26 — — WO claimed
WO-2015042397-A1 GLUCOSYLCERAMIDE SYNTHASE INHIBITORS FOR THE TREATMENT OF DISEASES BIOMARIN PHARMACEUTICAL INC. (US) 2015-03-26 — — WO disclosed
Send feedback